Weight Loss Diet Study: Low Carb vs Low Fat



Status:Completed
Conditions:Obesity Weight Loss, Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 50
Updated:6/9/2017
Start Date:April 2012
End Date:March 2013

Use our guide to learn which trials are right for you!

Weight Loss Diet Study: Low Carbohydrate vs. Low Fat and Insulin Resistance Status

The traditional weight loss diet recommended by health professionals has been a low-fat,
high-carbohydrate, calorie restricted diet. This recommendation has been challenged by a
number of alternative dietary strategies, particularly low-carbohydrate diets. In several
recent weight loss studies insulin resistant adults had more success with low- vs.
high-carbohydrate diets, in contrast to insulin sensitive adults who had either more success
or comparable success with the low-fat diets. The investigators enrolled 61 people with a
wide range of insulin sensitivity/resistance. After determining their insulin resistance
status, the investigators will split them in the middle and randomly assign them to one of
four groups for six months: (1) Low-Carbohydrate/Insulin Resistant (LC/IR); (2)
Low-Carbohydrate/Insulin Sensitive (LC/IS); (3) Low-Fat/Insulin Resistant (LF/IR); and (4)
Low-Fat/Insulin Sensitive (LF/IS) (15 people/group). After 6 months the participants will
switch diet for the following 6 months, i.e. those randomized to the Low-Carbohydrate diet
will switch to the Low-Fat diet and vice-versa. The primary outcome of this study is to
determine whether weight loss success can be increased if one follows the dietary approach
appropriately matched to their insulin resistance status. Secondary outcomes include fasting
insulin, glucose, lipids, and fatty acid composition.

The investigators hope to learn whether matching the weight loss diet to one's insulin
resistance status will increase weight loss the success. The relevance of these findings is
highlighted by the fact that the national recommendations for weight loss are to follow a
high-carbohydrate, low-fat diet. This would imply that about half the population has been
given the wrong advice in regards to the most successful dietary pattern for weight loss.

Plasma fatty acid composition patterns have been shown to be associated with both insulin
resistance and/or carbohydrate intake. As secondary analyses, the investigators will
explore: (1) differences in plasma fatty acid composition between insulin sensitive and
resistant participants at baseline; (2) the correlations between insulin markers and plasma
fatty acid composition at baseline; (3) the interaction between insulin status and diet on
6-month changes in the plasma fatty acid composition; (4) plasma fatty acid composition
changes in participants on low fat and low carbohydrate diets after 6 months; and (5) the
correlations between changes in insulin markers, dietary components, and plasma fatty acid
composition after 6 months.

Inclusion Criteria:

- Age: > or = 18 years of age

- Women: Pre-menopausal (self-report) and <50 years of age

- Men: <50 years of age

- Race/Ethnicity: All

- BMI (body mass index): 28-40 kg/m2 (need to lose >10% body weight to achieve healthy
BMI)

- Body weight stable for the last two months, and not actively on a weight loss plan

- No plans to move from the area over the next 14 months

- Available and able to participate in the evaluations and intervention for the study
period

- Willing to accept random assignment

- To enhance study generalizability, people on medications not noted below as specific
exclusions can participate if they have been stable on such medications for at least
three months

- Ability and willingness to give written informed consent

- No known active psychiatric illness

Exclusion Criteria:

- Pregnant, lactating, within 6 months post-partum, or planning to become pregnant in
the next 12 months; no menstruation for the previous 12 months

- Diabetes (type 1 and 2) or history of gestational diabetes or on hypoglycemic
medications for any other indication

- Prevalent diseases: Malabsorption, renal or liver disease, active neoplasms, recent
myocardial infarction, hypertension (except for those stable on hypertensive
medications) (<6 months) (patient self-report and, if available, review of labs from
primary care provider)

- Smokers (because of effect on weight and lipids)

- History of serious arrhythmias, or cerebrovascular disease

- Uncontrolled hyper- or hypothyroidism (TSH not within normal limits)

- Medications: Lipid lowering, diabetes medications, and those known to affect
weight/energy expenditure

- Excessive alcohol intake (self-reported, >3 drinks/day)
We found this trial at
1
site
291 Campus Dr
Stanford, California 94305
(650) 725-3900
Stanford University School of Medicine Vast in both its physical scale and its impact on...
?
mi
from
Stanford, CA
Click here to add this to my saved trials